E N D Presentation Transcript L-Carnitine Charisma Garcia NFSC 345 Introduction Background Purported Benefits Mechanism of Action Evidence of Benefits Conflicting Research Safety Concerns Professional Position L-Carnitine Essential for Energy Production Naturally Occurs in the Human Body Synthesized in the Liver & Kidneys Derived from the amino acid, Lysine Produces 11-34mg/day (Sufficient to meet all needs!) Dietary L-Carnitine Red meat, dairy, fish, wheat, asparagus, avocado Omnivorous diet: 20-200mg/day (~75% absorbed) No proof of Dietary need exists L-Carnitine as a Supplement Liquid form,Tablets & Capsules Typical Dose: 1000-6000 mg/day ~20% absorbed by the body Generally non-toxic Intended population: Athletes Dieters Purported Benefits Primary Systemic Carnitine Deficiency A recessive gene mutation Cardiovascular Disease Alzheimers Disease Chronic Fatigue In the Elderly Population In Cancer Patients Fat Loss No Evidence EXERCISE PERFORMANCE

Massage Massez en mouvements circulaires jusqu absorption complte
Bioavailability enhancers of herbal origin: an overview
P = 0.0007) g/L 16 (Mean differences [95% CI] in the changes from baseline between GLP-1-based therapy and control patients)
Why Titration Matters More for Retatrutide Than Other GLP-1s In the Phase 2 trial, GI adverse events (primarily nausea, vomiting, and diarrhea) affected 50 to 60 percent of participants at higher doses, according to Jastreboff et al